ID

44027

Description

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00771433

Lien

https://clinicaltrials.gov/show/NCT00771433

Mots-clés

Versions (2)
  1. 19/10/2017 19/10/2017 -
  2. 20/09/2021 20/09/2021 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT00771433

Anglais

Eligibility Breast Cancer NCT00771433

1 Formulaires  
Criteria
Description

Criteria

diagnosis of breast cancer
Description

Breast Carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0678222
receiving 1 of the following neoadjuvant or adjuvant chemotherapy regimens:
Description

Chemotherapy Regimen Neoadjuvant | Chemotherapy, Adjuvant

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0600558
UMLS CUI [2]
C0085533
six courses of epirubicin hydrochloride and docetaxel
Description

Epirubicin Hydrochloride | Docetaxel

Type de données

boolean

Alias
UMLS CUI [1]
C0700582
UMLS CUI [2]
C0246415
six courses of fluorouracil, epirubicin hydrochloride, and cyclophosphamide (fec) 100 or 3 courses of fec 100 and 3 courses of docetaxel 100
Description

Fluorouracil | Epirubicin Hydrochloride | Cyclophosphamide | FEC | docetaxel

Type de données

boolean

Alias
UMLS CUI [1]
C0016360
UMLS CUI [2]
C0700582
UMLS CUI [3]
C0010583
UMLS CUI [4]
C0060133
UMLS CUI [5]
C0246415
must have received at least 2 chemotherapy regimens prior to study therapy
Description

Chemotherapy Regimen Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
no malignant hematological disease
Description

Malignant disease Hematologic Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0442867
UMLS CUI [1,2]
C0205488
UMLS CUI [1,3]
C0332197
hormone receptor status not specified
Description

Hormone Receptor Status Unspecified

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205370
patient characteristics:
Description

Client Characteristics

Type de données

boolean

Alias
UMLS CUI [1]
C0815172
menopausal status not specified
Description

Menopausal Status Unspecified

Type de données

boolean

Alias
UMLS CUI [1,1]
C3829127
UMLS CUI [1,2]
C0205370
not pregnant or nursing
Description

Pregnancy Absent | Breast Feeding Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
fertile patients must use effective contraception
Description

Fertility Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no contraindications to standard neoadjuvant or adjuvant chemotherapy
Description

Contraindication Absent Chemotherapy Neoadjuvant | Contraindication Absent Adjuvant Chemotherapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0392920
UMLS CUI [1,4]
C0600558
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0085533
no known hypersensitivity to g-csf or any of its components
Description

Hypersensitivity Absent G-CSF | Hypersensitivity Absent G-CSF Component

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0079459
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0079459
UMLS CUI [2,4]
C1705248
no patients deprived of liberty or under guardianship
Description

Exclusion Prisoners | Exclusion Patients Guardianship Related

Type de données

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0033167
UMLS CUI [2,1]
C2828389
UMLS CUI [2,2]
C0030705
UMLS CUI [2,3]
C0870627
UMLS CUI [2,4]
C0439849
no psychological, familial, social, or geographical reasons preventing follow-up
Description

Condition Absent Preventing Follow-up

Type de données

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C1292733
UMLS CUI [1,4]
C3274571
prior concurrent therapy:
Description

Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Description

ID.17

Type de données

boolean

no concurrent participation in another experimental drug study
Description

Study Subject Participation Status | Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT00771433

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Breast Carcinoma
Item
diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
Chemotherapy Regimen Neoadjuvant | Chemotherapy, Adjuvant
Item
receiving 1 of the following neoadjuvant or adjuvant chemotherapy regimens:
boolean
C0392920 (UMLS CUI [1,1])
C0600558 (UMLS CUI [1,2])
C0085533 (UMLS CUI [2])
Epirubicin Hydrochloride | Docetaxel
Item
six courses of epirubicin hydrochloride and docetaxel
boolean
C0700582 (UMLS CUI [1])
C0246415 (UMLS CUI [2])
Fluorouracil | Epirubicin Hydrochloride | Cyclophosphamide | FEC | docetaxel
Item
six courses of fluorouracil, epirubicin hydrochloride, and cyclophosphamide (fec) 100 or 3 courses of fec 100 and 3 courses of docetaxel 100
boolean
C0016360 (UMLS CUI [1])
C0700582 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
C0060133 (UMLS CUI [4])
C0246415 (UMLS CUI [5])
Chemotherapy Regimen Quantity
Item
must have received at least 2 chemotherapy regimens prior to study therapy
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Malignant disease Hematologic Absent
Item
no malignant hematological disease
boolean
C0442867 (UMLS CUI [1,1])
C0205488 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Hormone Receptor Status Unspecified
Item
hormone receptor status not specified
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Menopausal Status Unspecified
Item
menopausal status not specified
boolean
C3829127 (UMLS CUI [1,1])
C0205370 (UMLS CUI [1,2])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Contraindication Absent Chemotherapy Neoadjuvant | Contraindication Absent Adjuvant Chemotherapy
Item
no contraindications to standard neoadjuvant or adjuvant chemotherapy
boolean
C1301624 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C0600558 (UMLS CUI [1,4])
C1301624 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0085533 (UMLS CUI [2,3])
Hypersensitivity Absent G-CSF | Hypersensitivity Absent G-CSF Component
Item
no known hypersensitivity to g-csf or any of its components
boolean
C0020517 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0079459 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0079459 (UMLS CUI [2,3])
C1705248 (UMLS CUI [2,4])
Exclusion Prisoners | Exclusion Patients Guardianship Related
Item
no patients deprived of liberty or under guardianship
boolean
C2828389 (UMLS CUI [1,1])
C0033167 (UMLS CUI [1,2])
C2828389 (UMLS CUI [2,1])
C0030705 (UMLS CUI [2,2])
C0870627 (UMLS CUI [2,3])
C0439849 (UMLS CUI [2,4])
Condition Absent Preventing Follow-up
Item
no psychological, familial, social, or geographical reasons preventing follow-up
boolean
C0348080 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C3274571 (UMLS CUI [1,4])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.17
Item
see disease characteristics
boolean
Study Subject Participation Status | Investigational New Drugs
Item
no concurrent participation in another experimental drug study
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial